In terms of fostering credibility, as opposed to ending up with egg all over the company's face, the use of the term "massive sulphide" as headlined in the announcement is quite a gambit. CCZ I am sure is well aware that if this turns out to be underwhelming in terms of copper assays, management will find it hard to recover any sense of credibility. Okay, they have covered themselves by carefully avoiding alluding to copper sulphide, but why would you headline the word "massive" if you even had an inkling there's nothing of value. I assume these guys are not dumb and are well aware of the heightened sense of anticipation the announcement headline has made, albeit not reflected in the share price reaction. I continue to hold, am not in the mood to sell, but not topping up either. Comfortable with my current holding and the fact I have a modest position, which potentially could multi-bag.
- Forums
- ASX - By Stock
- CCZ
- Ann: Massive Sulphide Mineralisation Drilled at Cangai
Ann: Massive Sulphide Mineralisation Drilled at Cangai, page-25
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCZ (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.797M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1055000 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3984328 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 655000 | 0.005 |
33 | 13328444 | 0.004 |
11 | 6907331 | 0.003 |
13 | 10159429 | 0.002 |
11 | 13002005 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3984328 | 9 |
0.007 | 1238258 | 8 |
0.008 | 2343047 | 6 |
0.009 | 3129561 | 4 |
0.010 | 2500000 | 3 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
CCZ (ASX) Chart |
Day chart unavailable